US equities |
SPCX $168.69 ▲+6.12% NVDA $237.52 ▲+1.53% MU $1,065.20 ▼-0.90% TSLA $380.39 ▲+2.64% MSFT $524.62 ▲+1.37% SNDK $1,714.67 ▼-0.31% INTC $116.82 ▼-2.10% META $744.05 ▲+2.19%
FinancialContent

Articles published by Clene Inc.

News headline image
Clene Reports New Data from the VISIONARY-MS Phase 2 Study in Multiple Sclerosis Demonstrating CNM-Au8® Treatment Improved Brain Neuronal Structural Integrity
From Clene Inc.
Via GlobeNewswire
Tickers CLNN
News headline image
Clene Nanomedicine Announces Participation in Renmark Virtual Non-Deal Roadshow Series on January 18 and January 23
From Clene Inc.
Via GlobeNewswire
Tickers CLNN
News headline image
Clene Nanomedicine Reports Topline Results of Phase 2 COVID-19 Study of CNM-ZnAg
From Clene Inc.
Via GlobeNewswire
Tickers CLNN
News headline image
Clene Announces Closing of $5 Million Debt Facility from the State of Maryland
From Clene Inc.
Via GlobeNewswire
Tickers CLNN
News headline image
VISIONARY-MS Trial Results Featured in Platform Presentation at PACTRIMS 2022: CNM-Au8® Demonstrated Global Neurological Improvement in Stable MS Patients as Adjunct to Background Disease Modifying Therapies
From Clene Inc.
Via GlobeNewswire
Tickers CLNN
News headline image
Clene Reports Third Quarter 2022 Financial Results and Recent Operating Highlights
From Clene Inc.
Via GlobeNewswire
Tickers CLNN
News headline image
Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland
From Clene Inc.
Via GlobeNewswire
Tickers CLNN
News headline image
Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial
From Clene Inc.
Via GlobeNewswire
Tickers CLNN
News headline image
Clene to Report HEALEY ALS Platform Trial Topline Results on Monday, October 3
From Clene Inc.
Via GlobeNewswire
Tickers CLNN